|
|
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY |
| 5 R01 HL146436-03 |
|
NHLBI |
2021 |
|
|
Molecular basis of telomere dysfunction in cardiac dystrophy |
| 5 R01 HL146662-03 |
|
NHLBI |
2021 |
|
|
Printed Electronic Biosensors for Point-of-Care Testing of Cardiovascular Biomarkers |
| 5 R01 HL146849-03 |
FRANKLIN, AARON |
NHLBI |
2021 |
|
|
Pathogenic mechanisms and therapeutics for the cardiac manifestations of myotonic dystrophy type 1 |
| 5 R01 HL147020-03 |
|
NHLBI |
2021 |
|
|
Effects of aortic compliance and Windkessel reduction on cardiac and aortic pathophysiology |
| 5 R01 HL147128-03 |
|
NHLBI |
2021 |
|
|
Cardiotoxicity in Total Joint Arthroplasty |
| 5 R01 HL147155-03 |
|
NHLBI |
2021 |
|
|
Sleep-disordered breathing in infants with myelomeningocele |
| 5 R01 HL147261-02 |
|
NHLBI |
2021 |
|
|
Voltage-gated sodium channels in lysosomal physiology |
| 5 R01 HL147379-03 |
|
NHLBI |
2021 |
|
|
Optimizing respiratory plasticity with chronic cervical SCI |
| 5 R01 HL147554-03 |
|
NHLBI |
2021 |
|
|
Cannula Tip with Integrated Volume and Pressor Sensors for Rotary Blood Pump Control |
| 5 R01 HL148064-02 |
|
NHLBI |
2021 |
